Key Facts Surrounding This News Item
- OVID had returned 0.00% year-to-date leading up to today’s news, versus a +11.63% return from the benchmark S&P 500 during the same period.
More Info About Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company was founded in 2014 and is based in New York City, New York. View our full OVID ticker page with ratings, news, and more.